Bayshore Pharmaceuticals Overview
- Founded
- 2011
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
Bayshore Pharmaceuticals General Information
Description
Provider of contract manufacturing services for pharmaceutical and nutraceutical market. The company specializes in the manufacturing of liquid dietary and vitamin supplements and offers various services including product inception, formulation, development, testing, distribution, packaging, portfolio commercialization, niche customer identification, and project management services, allowing clients to focus on what they do best.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Drug Discovery
Parent Company
Ipca Laboratories
Primary Office
- 1202 Tech Boulevard
- Suite 107
- Tampa, FL 33619
- United States
Bayshore Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Bayshore Pharmaceuticals‘s full profile, request access.
Request a free trialBayshore Pharmaceuticals Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| David Raiskin | Chief Executive Officer | ||
| Richard Cunningham | President & Chief Operating Officer |